TMO
Thermo Fisher Scientific Inc.
Stock
$675.05−4.56 (−0.67%)Close Sep 30, 2026
| Free cash flow (TTM) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $7.3B | +18.6% | −1.6% | 9.6% |
| Free cash flow (TTM) | $7.3B |
|---|---|
| YoY | +18.6% |
| 5-year CAGR | −1.6% |
| 10-year CAGR | 9.6% |
Free cash flow
| Period | Free cash flow | YoY |
|---|---|---|
| 2025 | $6.3B | −13.4% |
| 2024 | $7.3B | +4.9% |
| 2023 | $6.9B | +0.2% |
| 2022 | $6.9B | +1.8% |
| 2021 | $6.8B | −0.4% |
| 2020 | $6.8B | +68.4% |
| 2019 | $4.0B | +6.9% |
| 2018 | $3.8B | +8.2% |
| 2017 | $3.5B | +24.3% |
| 2016 | $2.8B | +11.7% |
| 2015 | $2.5B | +14.9% |
| 2014 | $2.2B | +26.8% |
| 2013 | $1.7B | +0.2% |
| 2012 | $1.7B | +20.6% |
| 2011 | $1.4B | +14.2% |
| 2010 | $1.3B | −14.2% |
| 2009 | $1.5B | +26.3% |
| 2008 | $1.2B | −11.6% |
| 2007 | $1.3B | — |